Haisco Pharmaceutical Hits Day High with 8.08% Surge in Stock Price

Haisco Pharmaceutical Group Co., Ltd. has experienced a significant surge in its stock price, gaining 8.08% on June 23, 2026. The stock reached an intraday high of CNY 54.15, showcasing its strong performance against the backdrop of a declining China Shanghai Composite, which fell by 1.37% on the same day. Over the past week, Haisco has demonstrated a robust performance with a 9.96% increase, while its one-month performance stands at 4.09%. The company has shown impressive annual growth, with a 24.53% increase over the past year, outperforming the Shanghai Composite's 21.43% gain. Notably, Haisco's three-year performance has soared by 140.88%, and its five-year growth is at 133.38%. Key financial metrics highlight Haisco's strong position in the pharmaceuticals and biotechnology sector. The company reported a remarkable net profit growth of 1089.85% in March 2026, alongside a record operating cash flow of CNY 1,126.55 million. With a return on equity of 15.84% and a high dividend yield of 1.2%, Haisco continues to solidify its standing in the market.